BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2010
View Archived Issues
GW-5074 has therapeutic activity in mouse model of Parkinson's disease
Read More
Phase II data on MK-0941 cast doubt on suitability for treatment of diabetes
Read More
Progenics Pharma advances phase III trial of Relistor for opioid-induced constipation
Read More
Imeglimin shows promise in phase II trials in type 2 diabetes
Read More
Phase I data presented on flu vaccine NB-1008 and acne therapy NB-003
Read More
CYT-003-QbG-10 is safe and efficacious in allergic asthma
Read More
SUN-13834 is efficacious in patients with atopic dermatitis
Read More
NCI selects Bexion to collaborate on cancer nanotherapeutic SapC-DOPS
Read More
Cel-Sci receives Russian approval for phase III Multikine trial
Read More
CHMP recommends approval of AstraZeneca's ticagrelor
Read More
Octapharma now withdrawing all lots of Octagam from U.S. market
Read More
Chelsea Therapeutics begins phase II CH-4051 trial in rheumatoid arthritis
Read More
Novartis' H5N1 vaccine Aflunov for adults gets positive opinion in E.U.
Read More
FDA approves phase Ib ibudilast trial in methamphetamine-dependent subjects
Read More
Actelion reports on CONSCIOUS-2 phase II trial of clazosentan in aSAH
Read More
AMT-080 receives FDA orphan drug status for Duchenne's muscular dystrophy
Read More
EP-1300 epitope-based DNA vaccine for malaria enters phase I
Read More
Pivotal trial data reported on brentuximab vedotin in Hodgkin's lymphoma
Read More
Advanced Targeting Systems receives NIH award to advance SP-SAP to clinic
Read More
Short-acting anesthetic/sedative remimazolam completes phase IIb trial
Read More
Nycomed submits European filing for marketing approval of EX-101
Read More
Studies point to potential benefit of ITI-007 in Parkinson's disease
Read More
GlaxoSmithKline claims new I-kappa-kinase beta inhibitors
Read More
Novel phosphatidylinositol 3-kinase inhibitors described
Read More
Gruenenthal discloses new voltage-gated K(V)7.2/3 potassium channel activators
Read More
Vanderbilt University claims novel GlyT-1 inhibitors
Read More